Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: NT 10-Q, Date: 2011-08-16
Original SEC Filing: Click here

---

Webplus: SKBI/20110816/NT_10-Q_1/1/000.htm SEC Original: v232252_nt10q.htm
PART II — RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: NT 10-Q, Date: 2011-08-16CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE